{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:28:46Z","timestamp":1794731326489,"version":"4.9.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["202502"],"award-info":[{"award-number":["202502"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272819"],"award-info":[{"award-number":["82272819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972888"],"award-info":[{"award-number":["81972888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BE2022840"],"award-info":[{"award-number":["BE2022840"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102399","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:42:26Z","timestamp":1759552946000},"page":"102399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence"],"prefix":"10.1016","volume":"6","author":[{"given":"Ciliang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkai","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4753-2648","authenticated-orcid":false,"given":"Junhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102399_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.102399_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"Bmj"},{"key":"10.1016\/j.xcrm.2025.102399_bib3","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s43018-024-00787-0","article-title":"Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer","volume":"5","author":"Fernandez-Mateos","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102399_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102399_bib7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(24)00215-7","article-title":"Stereotactic body radiotherapy with sequential tislelizumab and chemotherapy as neoadjuvant therapy in patients with resectable non-small-cell lung cancer in China (SACTION01): a single-arm, single-centre, phase 2 trial","volume":"12","author":"Zhao","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102399_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3682","article-title":"In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12951-022-01270-7","article-title":"Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs","volume":"20","author":"Zhao","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.xcrm.2025.102399_bib11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1158\/2159-8290.CD-21-0980","article-title":"Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse","volume":"12","author":"Gambacorta","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102399_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell-immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib13","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1002\/mco2.203","article-title":"Hypoxia signaling in cancer: Implications for therapeutic interventions","volume":"4","author":"Zhuang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.xcrm.2025.102399_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41591-024-02824-y","article-title":"Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial","volume":"30","author":"Kim","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib15","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41591-023-02593-0","article-title":"The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial","volume":"29","author":"Luke","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-024-01956-6","article-title":"Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison","volume":"23","author":"Cheng","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib17","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.1073\/pnas.96.26.15074","article-title":"Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy","volume":"96","author":"Kwon","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102399_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3104","article-title":"Biopolymer implants enhance the efficacy of adoptive T-cell therapy","volume":"33","author":"Stephan","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102399_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jhep.2024.06.042","article-title":"Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis","volume":"82","author":"Rezaee-Zavareh","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2025.102399_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","article-title":"Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours","volume":"24","author":"Holder","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib23","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa2401530","article-title":"Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy","volume":"390","author":"Ozdemirli","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib24","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/jama.2023.8753","article-title":"CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome","volume":"329","author":"Pecher","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2025.102399_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan4488","article-title":"Eradication of spontaneous malignancy by local immunotherapy","volume":"10","author":"Sagiv-Barfi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/1078-0432.CCR-13-2116","article-title":"Intratumoral immunization: a new paradigm for cancer therapy","volume":"20","author":"Marabelle","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102399_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Hofmann","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41580-024-00715-1","article-title":"Cellular and molecular mechanisms of skin wound healing","volume":"25","author":"Pena","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102399_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102399_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-022-00951-x","article-title":"Engineering strategies to enhance oncolytic viruses in cancer immunotherapy","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13578-023-01135-y","article-title":"The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies","volume":"13","author":"Guo","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.xcrm.2025.102399_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102399_bib35","article-title":"Thymosin \u03b11 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy","volume":"5","author":"Liu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.omto.2020.11.001","article-title":"Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2025.102399_bib37","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1038\/s41598-017-05500-z","article-title":"Oncolytic measles virus enhances antitumour responses of adoptive CD8(+)NKG2D(+) cells in hepatocellular carcinoma treatment","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102399_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41577-022-00719-y","article-title":"Tumour immunotherapy: lessons from predator-prey theory","volume":"22","author":"Hamilton","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102399_bib40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41392-023-01521-5","article-title":"Immunotherapy in hematologic malignancies: achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib42","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1039\/D1CS00786F","article-title":"Recent advances in biomaterial-boosted adoptive cell therapy","volume":"51","author":"Xue","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.xcrm.2025.102399_bib43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13046-019-1410-x","article-title":"Graphene oxide arms oncolytic measles virus for improved effectiveness of cancer therapy","volume":"38","author":"Xia","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102399_bib44","doi-asserted-by":"crossref","first-page":"28894","DOI":"10.1021\/acsnano.4c09097","article-title":"Small Molecule Hydrogels Loading Small Molecule Drugs from Chinese Medicine for the Enhanced Treatment of Traumatic Brain Injury","volume":"18","author":"Luo","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102399_bib45","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1021\/acsnano.9b10024","article-title":"High-Efficiency Fluorescence through Bioinspired Supramolecular Self-Assembly","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102399_bib46","article-title":"Multiple Stimuli-Responsive MXene-Based Hydrogel as Intelligent Drug Delivery Carriers for Deep Chronic Wound Healing","volume":"18","author":"Yang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2025.102399_bib47","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1039\/C4NR05798H","article-title":"Hierarchical construction of a mechanically stable peptide-graphene oxide hybrid hydrogel for drug delivery and pulsatile triggered release in vivo","volume":"7","author":"Wu","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.xcrm.2025.102399_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nature09024","article-title":"Designed biomaterials to mimic the mechanical properties of muscles","volume":"465","author":"Lv","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102399_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202200060","article-title":"Sustained Exosome-Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation","volume":"18","author":"Kwak","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.xcrm.2025.102399_bib50","article-title":"Designing Hydrogels for Immunomodulation in Cancer Therapy and Regenerative Medicine","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102399_bib51","doi-asserted-by":"crossref","first-page":"14877","DOI":"10.1021\/acsnano.3c08425","article-title":"Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity","volume":"18","author":"Fu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2025.102399_bib52","article-title":"In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix","volume":"36","author":"Livingston","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102399_bib53","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1002\/adfm.201603947","article-title":"Electrically Controllable Actuators Based on Supramolecular Peptide Hydrogels","volume":"26","author":"Xue","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.xcrm.2025.102399_bib54","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1021\/acsami.2c21297","article-title":"Bisphosphonate-Modified Functional Supramolecular Hydrogel Promotes Periodontal Bone Regeneration by Osteoclast Inhibition","volume":"15","author":"Hu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.xcrm.2025.102399_bib55","article-title":"Gel\/hydrogel-based in situ biomaterial platforms for cancer postoperative treatment and recovery","volume":"3","author":"Feng","year":"2023","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.xcrm.2025.102399_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102280","article-title":"Antibacterial hydrogel coating: Strategies in surface chemistry","volume":"285","author":"Zhao","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.xcrm.2025.102399_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymthe.2006.02.015","article-title":"Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication","volume":"14","author":"Huarte","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib58","doi-asserted-by":"crossref","first-page":"17286","DOI":"10.1073\/pnas.1009823107","article-title":"Induction of type I interferon by adenovirus-encoded small RNAs","volume":"107","author":"Yamaguchi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102399_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2016.10.012","article-title":"IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation","volume":"170","author":"Van den Bergh","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib60","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/cam4.934","article-title":"CXCL9: evidence and contradictions for its role in tumor progression","volume":"5","author":"Ding","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.xcrm.2025.102399_bib61","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.xcrm.2025.102399_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102399_bib63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41556-022-01085-6","article-title":"STAM and Hrs interact sequentially with IFN-alpha Receptor to control spatiotemporal JAK-STAT endosomal activation","volume":"25","author":"Zanin","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102399_bib64","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ymthe.2020.10.027","article-title":"Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma","volume":"29","author":"Zhang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13740","article-title":"Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10\/CXCR3 to boost antitumor immunity","volume":"58","author":"Zhang","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.xcrm.2025.102399_bib66","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1038\/s41467-023-38651-x","article-title":"Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies","volume":"14","author":"Azad","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102399_bib67","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.ymthe.2024.05.014","article-title":"A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses","volume":"32","author":"Rojas","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102399_bib68","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cac2.12579","article-title":"\"Find Me\" and \"Eat Me\" signals: tools to drive phagocytic processes for modulating antitumor immunity","volume":"44","author":"Xiao","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.xcrm.2025.102399_bib69","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1038\/s41467-019-12319-x","article-title":"Tissue-resident memory CD8(+) T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells","volume":"10","author":"Menares","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102399_bib70","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/0008-5472.CAN-20-1441","article-title":"Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity","volume":"81","author":"Sequeira","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102399_bib71","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","article-title":"Type I Interferons in Autoimmune Disease","volume":"14","author":"Crow","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.xcrm.2025.102399_bib72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.xcrm.2025.102399_bib73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-032414-112043","article-title":"Innate immune recognition of cancer","volume":"33","author":"Woo","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102399_bib74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.102399_bib75","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s13402-021-00633-w","article-title":"Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8(+) T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma","volume":"44","author":"Zhang","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.xcrm.2025.102399_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.574007","article-title":"Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102399_bib77","article-title":"The marriage of Xenes and hydrogels: Fundamentals, applications, and outlook","volume":"3","author":"Kang","year":"2022","journal-title":"Innovation"},{"key":"10.1016\/j.xcrm.2025.102399_bib78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-023-01797-9","article-title":"Nanomaterials in tumor immunotherapy: new strategies and challenges","volume":"22","author":"Zhu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102399_bib79","article-title":"Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics","volume":"36","author":"Albadawi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102399_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401745","article-title":"Mucus-Inspired Self-Healing Hydrogels: A Protective Barrier for Cells against Viral Infection","volume":"36","author":"Bej","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102399_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd0492","article-title":"Molecular design of stapled pentapeptides as building blocks of self-assembled coiled coil-like fibers","volume":"7","author":"Jiang","year":"2021","journal-title":"Sci. Adv."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:15:19Z","timestamp":1788563719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004720"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102399","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102399"}}